During the past decade, Szent Borbala Korhaz conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 9 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 6 clinical trials were completed. i.e. 23.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szent Borbala Korhaz" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Amgen" with 4 trials sponsored, "St. Borbala Hospital" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szent Borbala Korhaz" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Biological Research Centre, Szeged" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Department of Surgery, Bács-Kiskun Megyei Kórház, Kecskemét" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Szent Borbala Korhaz" are "Colorectal Cancer" (4 trials), "Ulcerative Colitis" (4 trials), "Gastric Cancer" (2 trials), "Gastroesophageal Junction Adenocarcinoma" (2 trials) and "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Szent Borbala Korhaz" in a lesser frequency.

Most popular intervention types in "Szent Borbala Korhaz" are "Drug" (34 trials), "Biological" (5 trials), "Other" (4 trials), "Combination Product" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Etrasimod" (4 trials), "Docetaxel" (3 trials), "Chemotherapy" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Szent Borbala Korhaz" are 37 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Szent Borbala Korhaz". undefined are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Szent Borbala Korhaz, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Szent Borbala Korhaz, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".